Gliclazide + Metformin Tablets(IR) bulk supplier for pharma manufacturers

Gliclazide + Metformin Tablets(Ir) Suppliers & Bulk Manufacturers

Available Forms: Tablets(IR)

Available Strengths: Gliclazide 80 mg + Metformin 500 mg

Reference Brands: Glizid-M, Glyciphage-G(US & EU)

Category: Diabetes

Gliclazide stimulates pancreatic β-cells to release insulin, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Together, they offer synergistic glucose control in type 2 diabetes. This dual-action therapy improves HbA1c levels, reduces fasting/postprandial glucose, and delays diabetes progression. Ideal for patients needing intensified glycemic control with oral agents.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Gliclazide + Metformin 80/500 mg immediate-release tablets are approved and marketed in several European and Asian countries, especially for Type 2 Diabetes Mellitus. This fixed-dose combination helps improve glycemic control by combining a sulfonylurea (Gliclazide) with a biguanide (Metformin). While widely available in the EU under brands like Glizid-M and Diamicron-M, this formulation is not approved by the U.S. FDA, as Gliclazide is not marketed in the U.S. Regulatory authorities in the EU assess it under EMA or national frameworks for fixed-combination antidiabetics. Pharmatradz.com lists reputable API manufacturers and global B2B sources for Gliclazide + Metformin IR tablets.

Gliclazide + Metformin Tablets(Ir) — third party manufacturing & bulk supply

Gliclazide + Metformin Tablets(Ir) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gliclazide + Metformin Tablets(Ir) is supplied as Tablets(IR) — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gliclazide + Metformin Tablets(Ir) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gliclazide + Metformin Tablets(Ir) →

Back to Listing

Frequently Asked Questions

Gliclazide + Metformin Tablets(IR) is listed as Tablets(IR) in Gliclazide 80 mg + Metformin 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Gliclazide + Metformin Tablets(IR) is referenced against Glizid-M, Glyciphage-G(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.